www.aldatubio.com Open in urlscan Pro
104.199.123.24  Public Scan

Form analysis
1 forms found in the DOM

GET https://www.aldatubio.com/

<form method="get" id="searchform" class="form-search center-text" action="https://www.aldatubio.com/">
  <label for="s" class="cfc-h-tx tt-upper">Type and Press “enter” to Search</label>
  <input type="text" id="s" class="search-query cfc-h-tx center-text tt-upper" name="s">
</form>

Text Content

al • da • tu [ɒl - də - tu]: to become something different


Navigation
 * PRODUCTS
   * HIV Drug Resistance
   * Lassa Fever Virus
   * SARS-CoV-2 [Detection]
   * SARS-CoV-2 [Variant Genotyping]
   * Enzymes
     * Hot Start RT
 * ABOUT
   * Technology
   * Our Story
   * Careers
   * News
   * Contact
 * R&D PIPELINE
 * ALDATU Dx
 * Search
 * 0 Items

 * PRODUCTS
   
   * HIV Drug Resistance
   * Lassa Fever Virus
   * SARS-CoV-2 [Detection]
   * SARS-CoV-2 [Variant Genotyping]
   * Enzymes
     
     * Hot Start RT
 * ABOUT
   
   * Technology
   * Our Story
   * Careers
   * News
   * Contact
 * R&D PIPELINE
 * ALDATU Dx
 * Search
 * 0 Items


THE LEADER IN ADAPTIVE PCR DIAGNOSTICS.

As your insurance policy against the unknown, our revolutionary detection and
genotyping technology – PANDAA – uniquely compensates for evolving pathogen
diversity, ensuring that PCR diagnostic integrity isn’t affected by genomic
variation now, or in the future.

Learn more



WHAT WE DO


AS A PUBLIC BENEFIT CORPORATION, OUR GOAL IS TO ADVANCE INFECTIOUS DISEASE
DIAGNOSTICS THAT FACILITATE SOCIETY'S COLLECTIVE RESPONSE TO GLOBAL HEALTH
EMERGENCIES.




AN INNOVATIVE PLATFORM FOR TARGET DETECTION IN HIGHLY VARIABLE GENOMIC REGIONS

Aldatu Biosciences has established the Pan Degenerate Amplification and
Adaptation (PANDAA™) platform to enable target detection in highly variable
genomic regions with RT-PCR. Our proprietary PANDAA technology allows the
development of fast, reliable, and cost-effective diagnostic tests for
infectious diseases.

Our pipeline includes products for the detection of SARS-CoV-2, Lassa virus, and
drug-resistant HIV variants. The high-throughput, low-cost PANDAA platform
improves patient healthcare access and outcomes. 



Aldatu Biosciences has established the Pan Degenerate Amplification and
Adaptation (PANDAA™) platform to enable target detection in highly variable
genomic regions with RT-PCR. Our proprietary PANDAA technology allows the
development of fast, reliable, and cost-effective diagnostic tests for
infectious diseases.

Our pipeline includes products for the detection of SARS-CoV-2, Lassa virus, and
drug-resistant HIV variants. The high-throughput, low-cost PANDAA platform
improves patient healthcare access and outcomes. 





ALDATU BIOSCIENCES ADDS ANOTHER OUTBREAK DISEASE TO PANDEMIC PREPAREDNESS
PORTFOLIO

Aldatu Biosciences, a biotechnology company developing molecular diagnostic
assays and products based on gold standard real-time PCR, today announced it has
been awarded a $3 Million Direct-to-Phase II Small Business Innovation Research
(SBIR) grant from the National Institute of Allergy and Infectious Diseases
(NIAID) at the National Institutes of Health (NIH). The award will fund the
continued advancement of the company’s proprietary PANDAA™ technology platform
and its specific application to the universal, pan-lineage detection of
Crimean-Congo Hemorrhagic Fever Virus (CCHFV), the causative agent of Crimean
Congo Hemorrhagic Fever (CCHF).

Read More »


SENIOR RESEARCH ASSOCIATE

The Person and Role We are seeking highly-motivated and talented senior research
associate to join our Assay Development team. Successful applicants will possess
strong molecular biology skills and a demonstrated interest in global health and
/ or infectious disease. Our

Read More »


ALDATU BEGINS OFFERING COVID19 TESTING SERVICES FOR HEALTH CARE PROVIDERS,
EMPLOYERS AND SCHOOLS

Aldatu Begins Offering COVID19 Testing Services for Health Care Providers,
Employers and Schools WATERTOWN, Mass., February 24, 2021 (PR Web) – Aldatu
Biosciences, the leader in adaptive PCR diagnostics, announced the opening of
new, expanded lab and R&D space in

Read More »



ACCOUNT

 * Sign up
 * Login


OUR COMPANY

 * Products
 * Our Story
 * Technology


RESOURCES

 * News
 * Contact
 * Terms and Conditions

Facebook-f Twitter Linkedin-in


© 2021 ALDATU BIOSCIENCES 2021.



Type and Press “enter” to Search